These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17941341)

  • 21. Tracking Cognitive Decline in Amnestic Mild Cognitive Impairment and Early-Stage Alzheimer Dementia: Mini-Mental State Examination versus Neuropsychological Battery.
    Kim J; Na HK; Byun J; Shin J; Kim S; Lee BH; Na DL
    Dement Geriatr Cogn Disord; 2017; 44(1-2):105-117. PubMed ID: 28768247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation and diagnostic accuracy of predictive curves for age-associated longitudinal cognitive decline in older adults.
    Bernier PJ; Gourdeau C; Carmichael PH; Beauchemin JP; Verreault R; Bouchard RW; Kröger E; Laforce R
    CMAJ; 2017 Dec; 189(48):E1472-E1480. PubMed ID: 29203616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies.
    Bilgel M; Koscik RL; An Y; Prince JL; Resnick SM; Johnson SC; Jedynak BM
    J Alzheimers Dis; 2017; 59(4):1335-1347. PubMed ID: 28731452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects.
    Visser PJ; Verhey FR; Scheltens P; Cruts M; Ponds RW; Van Broeckhoven CL; Jolles J
    J Neurol; 2002 Mar; 249(3):312-9. PubMed ID: 11993532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change in the mini-mental state exam in Alzheimer's disease over 2 years: the experience of a dementia clinic.
    McCarten JR; Rottunda SJ; Kuskowski MA
    J Alzheimers Dis; 2004 Feb; 6(1):11-5. PubMed ID: 15004323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The MMSE orientation for time domain is a strong predictor of subsequent cognitive decline in the elderly.
    Guerrero-Berroa E; Luo X; Schmeidler J; Rapp MA; Dahlman K; Grossman HT; Haroutunian V; Beeri MS
    Int J Geriatr Psychiatry; 2009 Dec; 24(12):1429-37. PubMed ID: 19382130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
    Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
    J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trajectories of cognitive decline in different types of dementia.
    Smits LL; van Harten AC; Pijnenburg YA; Koedam EL; Bouwman FH; Sistermans N; Reuling IE; Prins ND; Lemstra AW; Scheltens P; van der Flier WM
    Psychol Med; 2015 Apr; 45(5):1051-9. PubMed ID: 25229325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
    Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
    Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment.
    Wang D; Schultz T; Novak GP; Baker S; Bennett DA; Narayan VA
    J Alzheimers Dis; 2018; 62(2):855-865. PubMed ID: 29480187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls.
    Schrijnemaekers AM; de Jager CA; Hogervorst E; Budge MM
    J Clin Exp Neuropsychol; 2006 Apr; 28(3):438-55. PubMed ID: 16618630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.
    Henneges C; Reed C; Chen YF; Dell'Agnello G; Lebrec J
    J Alzheimers Dis; 2016; 52(3):1065-80. PubMed ID: 27079700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.
    Palmer K; Lupo F; Perri R; Salamone G; Fadda L; Caltagirone C; Musicco M; Cravello L
    J Alzheimers Dis; 2011; 24(1):35-45. PubMed ID: 21157019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes.
    Haaksma ML; Calderón-Larrañaga A; Olde Rikkert MGM; Melis RJF; Leoutsakos JS
    Int J Geriatr Psychiatry; 2018 Aug; 33(8):1057-1064. PubMed ID: 29761569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's disease.
    Langbaum JB; Ellison NN; Caputo A; Thomas RG; Langlois C; Riviere ME; Graf A; Lopez Lopez C; Reiman EM; Tariot PN; Hendrix SB
    Alzheimers Res Ther; 2020 May; 12(1):66. PubMed ID: 32460855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the Clock Drawing Test predict cognitive decline in older persons independent of the Mini-Mental State Examination? The FINE Study Group. Finland, Italy, The Netherlands Elderly.
    Ferrucci L; Cecchi F; Guralnik JM; Giampaoli S; Lo Noce C; Salani B; Bandinelli S; Baroni A
    J Am Geriatr Soc; 1996 Nov; 44(11):1326-31. PubMed ID: 8909348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical cognitive trajectories differ for Alzheimer's disease and vascular dementia.
    Laukka EJ; Macdonald SW; Fratiglioni L; Bäckman L
    J Int Neuropsychol Soc; 2012 Mar; 18(2):191-9. PubMed ID: 22264384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.